Cancer Research | American Association for Cancer Research

Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
COVID-19
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
COVID-19
Webinars

Skip Nav Destination

Current Issue

Volume 82,

Issue 13

1 July 2022

View This Issue

About the Journal

Cancer Research publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. Read More About the Journal

Editor-in-Chief

Chi Van Dang

View Full Editorial Board

Impact Factor

13.312

SUBMIT TO JOURNAL

Featured Articles

Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma

Bo Zhang, et al.

Epithelial–Mesenchymal Plasticity in Tumor Immune EvasionEpithelial–Mesenchymal Plasticity in Tumor Immune Evasion

Riley D.Z. Mullins, et al.

Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma

Shawn M. Davidson, et al.

Trending - Altmetric

Constitutive activation of the tumor suppressor p53 in hepatocytes paradoxically promotes non-cell autonomous liver carcinogenesis.

Last mentioned on Tuesday July 5 2022

Abstract P4-10-05: Safety and efficacy of low dose topical testosterone for sexual function improvement in women with breast cancer under treatment with ovarian suppression and aromatase inhibitor

Last mentioned on Monday July 4 2022

Adaptive Therapy

Last mentioned on Tuesday July 5 2022

Delineating The RAS Conformational Landscape

Last mentioned on Tuesday July 5 2022

Caspase-3-induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma

Last mentioned on Tuesday July 5 2022

Latest
Most Read
Most Cited

Autocrine GMCSF Signaling Contributes to Growth of HER2⁺ Breast Leptomeningeal Carcinomatosis

Sustained oncogenic signaling in the cytostatic state enables targeting of non-proliferating persistent cancer cells

CDK4/6 inhibition enhances oncolytic virus efficacy by potentiating tumor-selective cell killing and T cell activation in refractory glioblastoma

Targeting BCAT1 Combined with α-Ketoglutarate Triggers Metabolic Synthetic Lethality in Glioblastoma

Tweets by CR_AACR

Issues
Online First
Collections

News
Twitter

Online ISSN 1538-7445
Print ISSN 0008-5472

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers, & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Info for Librarians
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2022 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept